Status:
WITHDRAWN
Liposomal Bupivacaine in Shoulder Arthroscopy
Lead Sponsor:
University of Pennsylvania
Conditions:
Rotator Cuff Tears
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Background: The research study is being conducted to see if using the liposomal Bupivacaine for the Interscalene block will improve the patient pain control and the whole patient's experience 48 hour...
Detailed Description
Background: Shoulder arthroscopy is one of the most commonly performed ambulatory orthopedic procedures in the United States. However, despite advances in arthroscopic technique, significant postoper...
Eligibility Criteria
Inclusion
- physical ASA status I-III
- age greater than 18 years
- mental competency
- ability to provide informed consent for the study.
Exclusion
- severe pulmonary disease including chronic obstructive pulmonary disease(COPD)
- home oxygen use
- a preexisting chronic pain syndrome (defined as daily opioid intake for more than three months prior to surgery)
- allergies to any of the study medications or any of the medications in the multimodal analgesic regimen
- an inability to receive a nerve block due to anticoagulation status infection
- nerve injury
- patient refusal.
Key Trial Info
Start Date :
February 21 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 27 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04461028
Start Date
February 21 2019
End Date
June 27 2022
Last Update
March 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, United States, 19104